This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Annexon Biosciences (ANNX), McKesson (MCK) and Alector (ALEC)

Tipranks - Tipranks - Fri May 8, 11:24PM CDT

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Annexon Biosciences (ANNX), McKesson (MCK) and Alector (ALEC).

Claim 55% Off TipRanks

Annexon Biosciences (ANNX)

In a report released yesterday, Phil Nadeau from TD Cowen maintained a Buy rating on Annexon Biosciences. The company’s shares closed last Thursday at $5.52.

According to TipRanks.com, Nadeau is a 5-star analyst with an average return of 11.5% and a 49.0% success rate. Nadeau covers the Healthcare sector, focusing on stocks such as MoonLake Immunotherapeutics, XOMA Royalty Corporation, and BioMarin Pharmaceutical. ;'>

Annexon Biosciences has an analyst consensus of Strong Buy, with a price target consensus of $15.40.

See today’s best-performing stocks on TipRanks >>

McKesson (MCK)

TD Cowen analyst Charles Rhyee reiterated a Buy rating on McKesson yesterday and set a price target of $1012.00. The company’s shares closed last Thursday at $754.76.

According to TipRanks.com, Rhyee is a 4-star analyst with an average return of 2.7% and a 49.0% success rate. Rhyee covers the Healthcare sector, focusing on stocks such as BrightSpring Health Services, Inc., Fortrea Holdings Inc., and Charles River Labs. ;'>

Currently, the analyst consensus on McKesson is a Strong Buy with an average price target of $963.38, implying a 30.2% upside from current levels. In a report issued on April 28, William Blair also initiated coverage with a Buy rating on the stock with a $828.00 price target.

Alector (ALEC)

In a report released yesterday, Yaron Werber from TD Cowen maintained a Hold rating on Alector. The company’s shares closed last Thursday at $2.44.

According to TipRanks.com, Werber is a 5-star analyst with an average return of 25.1% and a 60.0% success rate. Werber covers the Healthcare sector, focusing on stocks such as Ultragenyx Pharmaceutical, Terns Pharmaceuticals, and Ionis Pharmaceuticals. ;'>

Currently, the analyst consensus on Alector is a Hold with an average price target of $3.63, which is a 41.8% upside from current levels. In a report released today, TipRanks – Anthropic also upgraded the stock to Hold with a $2.50 price target.

Read More on ANNX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).